Sodium-Glucose Cotransporter 2 Inhibitors in Cardiovascular and Renal Outcomes in Patients With Diabetes but Without Established Cardiovascular Disease: A Nationwide Population-Based Cohort Study

Diabetes Care. 2022 Sep 1;45(9):129-130. doi: 10.2337/dc22-0938.

Hao-Chih Chang^{1

2}, Tzu-Ting Kuo³, Yun-Yu Chen^{4

5}, Yenn-Jiang Lin^{2

4

6}, Hung-Yu Chang⁷, Chung-Lieh Hung^{8

9}, Fa-Po Chung^{2

4

6}

¹ Department of Medicine, Taipei Veterans General Hospital, Yuanshan and Suao Branch, Yilan, Taiwan.
² Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
³ Division of Cardiovascular Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
⁴ Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
⁵ Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
⁶ Institute of Clinical Medicine and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
⁷ Heart Center, Cheng Hsin General Hospital, Taipei, Taiwan.
⁸ Division of Cardiology, Departments of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan.
⁹ Institute of Biomedical Sciences, Mackay Medical College, New Taipei, Taiwan.

No abstract available

Publication types